| Tag | Content |
|---|
EnhancerAtlas ID | HS074-06345 |
Organism | Homo sapiens |
Tissue/cell | GM19239 |
Coordinate | chr17:28080240-28082260 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXC1 | MA0032.2 | chr17:28080939-28080950 | ATGTTTACATA | - | 6.32 | | IRF1 | MA0050.2 | chr17:28081362-28081383 | AAAGTGGAACTGAAAGAGCAT | - | 6.14 |
|
| | Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
| SE_09243 | chr17:28080743-28081803 | CD14 | | SE_10996 | chr17:28078074-28083023 | CD20 | | SE_18775 | chr17:28080793-28081728 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_58538 | chr17:28008486-28106930 | Ly1 | | SE_62296 | chr17:28008388-28106801 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I029753 | chr17 | 28080829 | 28082346 |
|
Enhancer Sequence | TGGGTTCAAG CGATTCTCCC TCCTCAGCCT CCCGAGTAGG TGGGATTACA GGCACCCACC 60
ATCATGCCCA GCTAATTTTT GTATTTTTGT AGAGATGGGG TTTCACCATG TTGTCCAGGC 120
TGGTCTCGAA CTCCTGACCT CAGGTGATAC CCCCAACCTC AGCCTCCCAA AGTGCTGGGA 180
TTATAGGTGT GAGCCACTGC GCCCGGCTTA TCTGCTATTA ATGTTATTAT TGGGGTTGGT 240
GAAGATATAG GGAAAGATAT GCCTACACAC TGCTGGTTAA GAGCAAATTG GTGGCCAGGT 300
GCGGTGCCTC ACGTCTGTAC TCCCAGCACT TTGGGAGGCC GAGGCAGGTG GATCACGAGG 360
TCAGGGGTTC GAGACCAGCC TGACCAAACA TGGTGAAACC CCGTCTGTAC TAAAAATACA 420
AAAATTAGCT GGGCGTGGTG GCGGGCACCT GTAATCCCAG CTACTCAGGA GGCTGAGGCA 480
GAATTGCTTG AACCTGGGAG GCAGAGGTTG CAGTGAGTTG AGATCGTGCC ACTGTACTCC 540
AGCCTGGGCG ATAGAGTGAG ACTCTGTCTG AAAAAAAAAA AAAAAAAGAA CAAATTGGTA 600
AAGTCTTTTT AGAAAGCAAT TTGGCTATAT GTATCAAATT TTTAACATAT ATACAACATT 660
AGGTCCAGCA ATTCCACCGC TAGAAATTTA TCTAAAGAAA TGTTTACATA TGTATACAAA 720
GATGTGTGTA TCAGGATTGT GAGTGCAGCA CTACAGGAGC TCTGGATTCA GAGACAAGAA 780
ATGCTTGTTC TAGTTTCAGT TCTACCATCA AGCCATGTAG CCTTGTGCAA ATCACTTCAG 840
CATTTTGATT CTCTAGTTTG TTATGCTATA AAATGTGGAC GATGACTTGC CCAATCTGCC 900
TCAGAGGAAT ACTTTAATTA AGGTAGGGTC CTTAGGCCAT CATCATCAGC ATCATCTAGG 960
AACTTGTTAG AAATGCAAAT TCTCCAGCCA CATCCTAGAC TTACAGAATC AGAAACTCTG 1020
GGGACTGTGG GTAGCAATTT GTGTTTTACC AAGCCCTCCA GGTGATTCTG ATGCAAGCTT 1080
AAGTTTGGAG ATAAGTTCAT GTGAAACCCC TTGTACAACT ACAAAGTGGA ACTGAAAGAG 1140
CATTAGTACT ATTACTAATA CAAAAAATAA GACTTTCTAC CTTTTGATTT CATGAAAAGG 1200
TACATTTTGG ATGAACATCC AATATGCTCC TCTACTGCTG ACGCTGAGCC TTAGAAAGCA 1260
CTCATGTGCT TCTAGGAAGT CAAGTTCATA TATGAACCAA GTAAATAAAT AAAAATATTT 1320
TAGGTCAAGT ATATAAAAAG CTTAAGATAA CCTCAACAGC AAATCAAGCA ATGTTTCAGT 1380
GCCTTAGTTT CAAGACAAGA CTTTTTTGAT CAGAGGTTTT CATAATGGGA ATATTTTATT 1440
TTATTTTTAT TTATTTATTT TTGAGACAGG GTTTTGCTCT GTTGCCCAGG CTGAAGTGAA 1500
GTGGCACCAT CTCGGCTCAC TGCAACCTCT GCCTCTCTGG CTCACACCAT CCTCCCACCT 1560
CAGCCTCCCA AGTAGCTGGC ACTACAGGCA CGCACCACCA TGCCCAGCTA ATTTTTTGTA 1620
AAGACAGGGT CTCCCTGTGT TGCTCAGGCT GGTCTTAAAC TCCTGGGCTC AAGGGATCCA 1680
CCTGCTTCGG CCTCCCAAAG AATTGAGATT ATAGGCGTGA GCCACTGCAC CCAGCCGGGA 1740
ATATTTTAAA TGGTAGTCTT TGCCAGAATT TTATCTAACA ATTTTTATTC TTCCCTGAGC 1800
TTCTTAGGAC ACAAAAATGG CCACTTGTTT AGTATATAAT GATAACACTA ACACCTTGGC 1860
TCCTTGCTTA GTGACTACTT CCCAGGGACT GGATAATAGC TCTCTAAAAA ATAATACAGG 1920
CTTCCATATT TTTCAGAAGT TCAGCTTTTT GTTTTACTAA AATGCACGTA CAGACTCTTA 1980
AAGGGTATGA ACTTTTTATG ATCATTCTCA TCAGTCTAAT 2020
|
